Clinical Trials
All Clinical Trials - Page 17 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05680129Phase 3Completed
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Dulaglutide
- NCT05606913Phase 3Completed
A Study of IBI362 in Participants With Type 2 Diabetes
Dulaglutide
- NCT05628311Phase 3Completed
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Mazdutide
- NCT05646706Phase 3Completed
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
Semaglutide
- NCT05594095Phase 2Recruiting
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Gonadorelin
- NCT05659537Phase 4Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Dulaglutide
- NCT05709444Phase 2Completed
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
PT-141
- NCT06201819Phase 4Completed
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Liraglutide
- NCT05633966Phase 1Completed
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Kisspeptin
- NCT05087342Phase 3Completed
Latino Semaglutide Study
Semaglutide
- NCT05610800Phase 2Completed
Exenatide for Smoking Cessation and Prevention of Weight Gain
Exenatide
- NCT05616052Phase 4Unknown
Comparison of Body Weight Change Through Different Smeglutide Administration Methods
Semaglutide
- NCT05163106Phase 2Completed
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole
Gonadorelin
- NCT05767255Phase 3Unknown
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
Liraglutide
- NCT05564039Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
Tirzepatide
- NCT05768945N/ACompleted
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Semaglutide
- NCT06217848EARLY_Phase 1Unknown
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Liraglutide
- NCT05598008N/ACompleted
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
Liraglutide
- NCT05347147Phase 3Terminated
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Exenatide
- NCT05611957Phase 1Completed
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Retatrutide
- NCT05616013Phase 2Completed
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Semaglutide
- NCT05623839Phase 1Completed
A Study of LY3305677 in Participants With Obesity Or Overweight
Mazdutide
- NCT05607680Phase 3Completed
A Study of IBI362 in Participants With Obesity or Overweight
Mazdutide
- NCT05582096Phase 1Completed
A Study of LY3457263 in Obese Participants
Tirzepatide
- NCT05448547Phase 3Recruiting
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Gonadorelin
- NCT05567796Phase 3Active Not Recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Semaglutide
- NCT05195944Phase 4Enrolling By Invitation
Semaglutide vs Sitagliptin
Semaglutide
- NCT05548231Phase 1Completed
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
Retatrutide
- NCT05443191N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
Semaglutide
- NCT05573230Phase 1Completed
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
Orforglipron
- NCT05567731N/ACompleted
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
Gonadorelin
- NCT05516966Phase 1Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
Dulaglutide
- NCT05556512Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Tirzepatide
- NCT05564117Phase 3Completed
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
Semaglutide
- NCT05254314Phase 2Active Not Recruiting
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Semaglutide
- NCT05210582Phase 2Unknown
A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face
Afamelanotide
- NCT05440383Phase 3Completed
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Gonadorelin
- NCT05313529N/AActive Not Recruiting
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Liraglutide
- NCT05766358N/ACompleted
Role Of Metabolic Adaptation In Weight Regain
Tirzepatide
- NCT05444153Phase 3Withdrawn
Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
Semaglutide
- NCT05658692Phase 4Unknown
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Thymosin-Alpha-1
- NCT04885634Phase 3Withdrawn
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Semaglutide
- NCT05390892Phase 4Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Semaglutide
- NCT04599686N/AUnknown
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
Gonadorelin
- NCT05520775Phase 2Completed
Semaglutide for Alcohol Use Disorder
Semaglutide
- NCT05302596Phase 2Completed
Semaglutide Use in Elderly Obese Patients
Semaglutide
- NCT06297564N/ACompleted
Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments
Gonadorelin
- NCT05545800Phase 3Unknown
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
Liraglutide
- NCT05438186N/AWithdrawn
INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
Liraglutide
- NCT05492305N/AUnknown
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Semaglutide